THRESHOLD PHARMACEUTICALS INC·3

Feb 4, 3:47 PM ET

PROQUEST INVESTMENTS II ADVISORS FUND LP 3

3 · THRESHOLD PHARMACEUTICALS INC · Filed Feb 4, 2005

Insider Transaction Report

Form 3
Period: 2005-02-04
Holdings
  • Common Stock

    3,301,565
  • Common Stock

    138,640
  • Common Stock

    (indirect: By LLC)
    3,440,205
Footnotes (4)
  • [F1]This line of Form 3 reports the direct beneficial ownership of shares of Threshold Pharmaceuticals, Inc. ("Threshold") by ProQuest Investments II, L.P., a Delaware limited partnership ("Investments II").
  • [F2]This line of Form 3 reports the direct beneficial ownership of shares of Threshold by ProQuest Investments II Advisors Fund,L.P., a Delware limited partnership ("Advisors").
  • [F3]This line of Form 3 reports the indirect beneficial ownership of shares of Threshold by ProQuest Associates II LLC ("Associates"), as the general partner of each of Investments II and Advisors, and by Jay Moorin and Alain Schreiber, as managing members of Associates.
  • [F4]The filing of this Form 3 shall not be deemed an admission that the Reporting Persons are or were, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the beneficial owners of any securities covered by this Form. Each of the Reporting Persons disclaims beneficial ownership in the securities covered by this Form except to the extent such Reporting Persons' pecuniary interest in such securities.

Documents

4 files